Cargando…
Quality assurance for the EORTC 22071–26071 study: dummy run prospective analysis
PURPOSE: The phase III 22071–26071 trial was designed to evaluate the addition of panitumumab to adjuvant chemotherapy plus intensity modulated radiotherapy (IMRT) in locally advanced resected squamous cell head and neck cancer. We report the results of the dummy run (DR) performed to detect deviati...
Autores principales: | Fairchild, Alysa, Langendijk, Johannes A, Nuyts, Sandra, Scrase, Christopher, Tomsej, Milan, Schuring, Danny, Gulyban, Akos, Ghosh, Sunita, Weber, Damien C, Budach, Wilfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311463/ https://www.ncbi.nlm.nih.gov/pubmed/25424399 http://dx.doi.org/10.1186/s13014-014-0248-9 |
Ejemplares similares
-
Quality assurance of radiotherapy in the ongoing EORTC 22042–26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case Reviews
por: Coskun, Mehtap, et al.
Publicado: (2013) -
Quality assurance of radiotherapy in the ongoing EORTC 1420 “Best of” trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedure
por: Stelmes, J-J, et al.
Publicado: (2021) -
A comprehensive quality assurance program for four-dimensional computed tomography in radiotherapy
por: Bakkali Tahiri, Jinane, et al.
Publicado: (2023) -
Results of a multicenter 4D computed tomography quality assurance audit: Evaluating image accuracy and consistency
por: Burghelea, Manuela, et al.
Publicado: (2023) -
Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee
por: Psyrri, A., et al.
Publicado: (2010)